Palliative Care

Top Story

Monthly cost of oral cancer drugs rises steadily over time

Monthly cost of oral cancer drugs rises steadily over time
April 28, 2016

The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter published in JAMA Oncology.

High drug prices can affect patient adherence to cancer therapies and increase the financial burden of medical care, according to Stacie B. Dusetzina, PhD, assistant professor of pharmaceutical outcomes and policy at University of North Carolina Eshelman School of Pharmacy.

In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment disorder —…
Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice President Joe Biden said…
Meeting News Coverage

AACR presents several scientific awards

April 17, 2016
NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting. Sir Richard S. Peto
CME

The Patient with Lymphadenopathy

No commercial support for this activity.

Castleman’s disease is a rare lymphoproliferative disorder that is characterized by enlargement of 1 (unicentric) or…
More »
Video
Meeting News Coverage

VIDEO: Innovation in CAR T-cell design may help improve safety, efficacy

April 25, 2016
More »
Featured
At Issue: Multiple Myeloma Resource Center

At Issue: Multiple Myeloma Resource Center

CME

The Patient with Myelofibrosis

No commercial support for this activity.

Myelofibrosis is caused by abnormal stem cells in the bone marrow that cause the uncontrolled production of mature…
More »
In the Journals

Monthly cost of oral cancer drugs rises steadily over time

April 28, 2016
The cost of oral cancer drugs in their first year on the market has increased significantly since the year 2000, according to a research letter…
In the Journals

Cancer diagnosis increases risk for mental disorders, psychiatric medication use

April 28, 2016
Patients diagnosed with cancer faced an increased risk for common mental disorders — such as depression, anxiety and stress reaction/adjustment…
Meeting News Coverage

Biden: Realignment of research incentives key to cancer moonshot initiative

April 20, 2016
A redesign of the cancer research enterprise is necessary to accelerate advances and achieve 10 years’ worth of progress in 5 years, Vice…
Meeting News Coverage

AACR presents several scientific awards

April 17, 2016
NEW ORLEANS The American Association for Cancer Research will recognize several clinicians and researchers during its annual meeting. Sir
Meeting News Coverage

AACR Annual Meeting begins this weekend

April 14, 2016
NEW ORLEANS — The HemOnc Today and Healio.com/HemOnc team will present comprehensive live coverage from the American Association for Cancer…

ASCO to honor researchers, scientists at annual meeting

April 1, 2016
ASCO will recognize several researchers and scientists during the society’s annual meeting, scheduled for June 3-7 in Chicago.“The…
In the Journals

Dying at home does not hasten death among patients with cancer

March 28, 2016
Patients with cancer who died at home experienced similar or significantly longer time until death than those who died in a hospital, according to…
CME

The Patient with Castration-resistant Prostate Cancer

March 15, 2016 Expires: 3/15/2017
Castration-resistant prostate cancer (CRPC) is a heterogeneous condition that encompasses a continuum of disease, beginning as increasing prostate…
In the JournalsPerspective

Morphine more effective than weak opioids for cancer-associated pain

February 16, 2016
Low-dose morphine significantly reduced pain intensity compared with weak opioids in patients with cancer, according to results of a randomized…
CME

The Patient with Multiple Ecchymoses

February 15, 2016 Expires: 2/15/2017
Glanzmann’s thrombasthenia is a rare, inherited bleeding disorder that results from a mutation in αIIbß3, an integrin present on the surface of the…
More Headlines »
morganatic-roan